98%
921
2 minutes
20
Purpose: Invasive micropapillary carcinoma (IMPC) is one of the rare subtypes of breast cancer. This study aimed to explore a predictive nomogram model for IMPC prognosis.
Methods: A total of 1855 IMPC patients diagnosed after surgery between 2004 and 2014 were identified from the Surveillance, Epidemiology and End Results (SEER) database to build and validate nomogram. A nomogram was created based on univariate and multivariate Cox proportional hazards regression analysis. Receiver operating characteristic (ROC) curves were used to demonstrate the accuracy of the prognostic model. Decision curve analysis (DCA) was performed to evaluate the safety of the model in the range of clinical applications, while calibration curves were used to validate the prediction consistency.
Results: Cox regression analysis indicated that age ≥62 at diagnosis, negative ER status, and tumor stage were considered adverse independent factors for overall survival (OS), while patients who were married, white or of other races, received chemotherapy or radiotherapy, had a better postoperative prognosis. The nomogram accurately predicted OS with high internal and external validation consistency index (C index) (0.756 and 0.742, respectively). The areas under the ROC curve (AUCs) of the training group were 0.787, 0.774 and 0.764 for 3, 5 and 10 years, respectively, while those of the validation group were 0.756, 0.766 and 0.762, respectively. The results of both DCA and calibration curves demonstrated the good performance of the model.
Conclusions: A nomogram for IMPC of the breast patients after surgery was developed to estimate 3, 5 and 10 years-OS based on independent risk factors. This model has good accuracy and consistency in predicting prognosis and has clinical application value.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134302 | PMC |
http://dx.doi.org/10.1002/cam4.5595 | DOI Listing |
Cancer Control
August 2025
Cellular and Molecular Biology Laboratory, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
IntroductionTertiary lymphoid structures (TLSs) have been associated with the prognosis of various solid tumors. However, the association between TLSs and the prognosis of invasive lung adenocarcinoma (IAC) remains unclear in terms of location, density, and maturity.MethodsWe retrospectively reviewed the clinicopathological characteristics of 750 patients with IAC.
View Article and Find Full Text PDFEur J Cardiothorac Surg
August 2025
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Objectives: Micropapillary (MP) and solid (S) pathological patterns are known to correlate with poor prognosis in invasive adenocarcinoma (IAC). Meanwhile, ground-glass opacity (GGO) components have been identified as a protective factor in IAC. This study investigated the prognostic significance of GGO component in IAC ≤3 cm with MP/S pathological patterns.
View Article and Find Full Text PDFFront Oncol
August 2025
Deparment of Cardiothoracic Surgery, Tianjin Medical University General Hospital Airport Hospital, Tianjin, China.
Objective: To explore the influencing recurrence in patients with stage IA lung adenocarcinoma following surgical resection.
Method: A retrospective analysis was conducted on the clinical and pathological data of patients with stage IA lung adenocarcinoma who underwent surgical resection in the Department of Thoracic Surgery at Tianjin Medical University General Hospital from January 1, 2018, to December 31, 2021. The Fine-Gray model was utilized for multivariate analysis to identify factors influencing the cumulative incidence of lung cancer recurrence.
Front Immunol
August 2025
Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Background: Invasive micropapillary carcinoma (IMPC) is a rare histopathological subtype of breast cancer (BC) that shows a high incidence of human epidermal growth factor receptor 2 (HER2)-positive expression. However, the therapeutic efficacy of current standard anti-HER2 therapies for this distinct BC subtype remains unclear.
Methods: We retrospectively analyzed patients with HER2-positive BC who underwent neoadjuvant therapy with trastuzumab (H) or trastuzumab plus pertuzumab (HP) between 2015 and 2023 at Sun Yat-sen University Cancer Center.
A female patient in her 60s tested positive for the fecal occult blood test while undergoing health screening. Colonoscopy revealed a 15-mm-sized flat elevated lesion with a central depression in the sigmoid colon. Narrow-band imaging magnification revealed a Japan Narrow-Band Imaging Expert Team classification of type 2B, whereas crystal violet staining showed a mild to severely irregular type VI pit pattern.
View Article and Find Full Text PDF